EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
53 hedge funds and large institutions have $118M invested in Eiger BioPharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less capital invested
Capital invested by funds: $120M → $118M (-$2.51M)
Holders
53
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.03M | |
| 2 | +$619K | |
| 3 | +$600K | |
| 4 |
Renaissance Technologies
New York
|
+$583K |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$542K |
Top Sellers
| 1 | -$3.46M | |
| 2 | -$1.72M | |
| 3 | -$1.16M | |
| 4 |
UC
Unterberg Capital
New York
|
-$976K |
| 5 |
Millennium Management
New York
|
-$871K |